期刊文献+

血尿酸水平及饮酒与帕金森病的相关性研究 被引量:2

Correlative study of serum uric acid, drinking and occurrence of Parkinson's disease
下载PDF
导出
摘要 目的研究血尿酸水平及饮酒与帕金森病发病风险的相关性。方法采用回顾性研究方法,选取2013年1月至2015年12月我院收治的帕金森病患者128例作为研究组,同期健康体检者117例作为对照组,分析帕金森病发病风险的影响因素。结果升高的血尿酸水平能降低帕金森病发病风险(OR=0.38,95%CI:0.26~0.61),以性别分组后,仍存在这一相关性。不饮酒人群中,血尿酸水平升高,帕金森病的发病风险降低(OR=0.43,95%CI:0.36~0.75)。结论高尿酸水平能降低帕金森病的发病风险,饮酒可能改变了其对帕金森病的保护作用。 Objective To investigate the relationship between serum uric acid levels, drinking and the occurrence of Parkinson's disease. Methods A retrospective study was carried out, one-hundred and twenty-eight cases of patients with parkinson's disease in our hospital from January, 2013 to December 2015 were selected as the study group, and 117 cases of health subjects at the same term were enrolled as the control group. The risk factors for parkinson disease were analyzed. Results Elevating serum uric acid levels reduced the risk of Parkinson's disease (OR=0.38, 95%CI: 0.26-0.61), and this correlation still existed when the people were grouped and analyzed by sex. In no drinking people, the elevation of serum uric acid levels reduced the risk of parkinson's disease (OR=0.43, 95%CI: 0.36-0.75). Conclusion High uric acid levels can reduce the risk of Parkinson's disease, drinking may affect its protective effect on the disease of Parkinson.
出处 《临床医学研究与实践》 2017年第2期4-5,7,共3页 Clinical Research and Practice
关键词 尿酸水平 帕金森病 饮酒 uric acid levels parkinson's disease drinking
  • 相关文献

参考文献2

二级参考文献30

  • 1Berardelli A,Wenning GK,Antonini A,et al.EFNS/MDSES/ENS[corrected]recommendations for the diagnosis of Parkinson's disease.Eur J Neurol,2013,20:16-34. 被引量:1
  • 2Moccia M,Picillo M,Erro R,et al.Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's disease.Eur J Neurol,2015,22:93-98. 被引量:1
  • 3Moccia M,PappatàS,Erro R,et al.Uric acid relates to dopamine transporter availability in Parkinson's disease.Acta Neurol Scand,2015,131:127-131. 被引量:1
  • 4Gagne JJ,Power MC.Anti-inflammatory drugs and risk of Parkinson disease:a meta-analysis.Neurology,2010,74:995-1002. 被引量:1
  • 5Tomlinson CL,Stowe R,Patel S,et al.Systematic review of levodopa dose equivalency reporting in Parkinson's disease.Mov Disord,2010,25:2649-2653. 被引量:1
  • 6Shadrina MI,Slominsky PA,Limborska SA.Molecular mechanisms of pathogenesis of Parkinson's disease.Int Rev Cell Mol iol,2010,281:229-266. 被引量:1
  • 7Shen C,Guo Y,Luo W,et al.Serum urate and the risk of Parkinson's disease:results from a meta-analysis.Can J Neurol Sci,2013,40:73-79. 被引量:1
  • 8O'Reilly EJ,Gao X,Weisskopf MG,et al.Plasma urate and Parkinson's disease in women.Am J Epidemiol,2010,172:666-670. 被引量:1
  • 9Chen X,Wu G,Schwarzschild MA.Urate in Parkinson's disease:more than a biomarker?Curr Neurol Neurosci Rep,2012,12:367-375. 被引量:1
  • 10Zhang ZX,Chen H,Chen SD,et al.Chinese culture permeation in the treatment of Parkinson disease:a cross-sectional study in four regions of China.BMC Res Notes,2014,7:65. 被引量:1

共引文献15

同被引文献19

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部